相关实验视频

Updated: Sep 13, 2025

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

工程天生的免疫力:最近的进展和未来的方向对CAR-NK和CAR-巨治疗在固体瘤

Behzad Amoozgar¹, Ayrton Bangolo¹, Charlene Mansour²

¹Department of Hematology and Oncology, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ 07601, USA.

|July 29, 2025

概括

化学抗原受体工程自然杀手细胞 (CAR-NK) 和巨细胞 (CAR-MΦ) 显示出对固体瘤的希望,克服了CAR-T细胞的局限性. 创新和早期试验表明,耐用,瘤选择性工程细胞疗法的潜力.

科学领域:

免疫治疗是一种免疫疗法.
细胞疗法细胞疗法
在瘤学瘤学.

背景情况:

收养细胞疗法彻底改变了血液癌症的治疗方法.
固体瘤存在诸如抗原异质性和免疫抑制性瘤微环境 (TME) 等挑战.
传统的仿真抗原受体-T (CAR-T) 细胞在固体瘤疗效方面面临限制.

研究的目的:

审查对固体瘤的CAR-NK和CAR-MΦ细胞疗法的进展.
突出CAR设计和制造平台的创新.
讨论挑战和未来的组合策略,以提高有效性.

主要方法:

关于CAR-NK和CAR-MΦ疗法的最新临床前和早期临床研究的综述.
分析新的CAR设计,包括信号域和效应器结构.
诱导多能干细胞 (iPSC) 衍生平台的检查.

主要成果:

CAR-NK和CAR-MΦ细胞通过MHC不受限制的细胞毒性,细胞化和细胞因子分泌表现出增强的抗瘤活性.
早期的临床数据显示可行性和TME调制与CAR-MΦ治疗.
创新包括对TME响应的CAR和可扩展的iPSC衍生平台.

结论:

在固体瘤中,CAR-NK和CAR-MΦ细胞为CAR-T细胞提供了有希望的替代品.
解决诸如体内持久性和制造复杂性等挑战至关重要.
组合策略和先进的CAR设计可能会导致持久的,瘤特异性反应.

关键词:

在CAR-NK细胞中.在CAR巨细胞中.采用细胞疗法采用细胞疗法细胞疗法是细胞疗法.组合免疫疗法组合免疫疗法细胞因子细胞因子血液学血液学血液学这就是 iPSC 的意义.这是先天免疫力.瘤学在瘤学方面.发酵细胞的形成发酵细胞的形成固体瘤是一种固体瘤.瘤微环境是一个微环境.

更多相关视频

Studying Interactions between Myeloid Cells and CAR T Cells In Vitro and In Vivo

Studying Interactions between Myeloid Cells and CAR T Cells In Vitro and In Vivo

Published on: July 25, 2025

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Published on: June 14, 2024

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.